Episodes (Page 15)
✨
Medipost CEO Edward Ahn discusses stem cell therapy vision.
Edward Ahn
✨
Astellas invests heavily in gene therapy despite industry challenges.
Richard Wilson
✨
Merck & Co. acquires Verona; venture funding drops in Q2.
✨
GLP-1 agonists are booming for obesity treatment.
Mathieu Millette
✨
Financial market stress creates deal-making opportunities.
✨
Scancell CEO Phil L'Huillier discusses cancer vaccine progress.
✨
Agnès Arbat discusses OxoLife's novel approach to female infertility.
Agnes Arbat
✨
Poverty increases likelihood of self-treatable health conditions.
Emese Csoke
✨
AbbVie's autoimmune CAR-T acquisition; growing CAR-T interest.
✨
Acuitas CSO Ying Tam on CRISPR delivery breakthrough.
Ying Tam
✨
Impact of 'Trumponomics' tariffs on India's pharmaceutical industry.
✨
Alzheimer's Drug Discovery Foundation invests like a VC.
Karen Harris
✨
Obesity drug developers focus on muscle preservation.
✨
Oncology experts discuss ASCO 2025 conference highlights.
✨
Biotechs rethink trials and embrace real-world data.
✨
Top drugs in Q1; deal trends at BIO; obesity plans.
✨
Mood at BIO International Convention and US economic outlook.
✨
FDA's Diversity Action Plan guidance creates uncertainty.
✨
Biotech uses competitive intelligence and AI to outsmart rivals.
✨
US policies spotlighted at BIO; Lilly's Verve acquisition.